Your session is about to expire
← Back to Search
Virtual Yoga for Insomnia in Cancer Survivors
Study Summary
This trial is examining whether a four-week yoga intervention delivered virtually is effective in improving insomnia and sleep quality in cancer survivors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a cancer survivor without sleep apnea or restless leg syndrome.My cancer has not spread to distant parts of my body.If you have had cancer and want to participate in the study, you should not have done yoga in the past three months.I have had surgery, chemotherapy, or radiation therapy for my cancer.I often have trouble sleeping.I finished my cancer treatment between 2 months and 10 years ago.I can safely participate in yoga without health risks.I am a cancer survivor not on treatment, except for hormone or biologic therapy.I can attend 8 online yoga sessions.I am not planning to start yoga on my own while in the study.I have a confirmed cancer diagnosis.I am 18 years old or older.I can read and understand English.
- Group 1: Standard Care
- Group 2: YOCAS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being taken into this medical trial?
"Yes, the information on clinicaltrials.gov validates that this research trial is currently recruiting. It was initially published on December 1st 2022 and had its most recent update on January 25th 2022. The study has 2 sites where 42 participants are being sought after."
What is the intended outcome of this research?
"The primary endpoint of this clinical trial, which will be evaluated from baseline to week 5, is the Mean shift in insomnia as documented by Insomnia Severity Index (ISI) overall score between caregivers who receive Partnered YOCAS compared to Standard Care. Secondary objectives include gauging a divergence in sleep quality among cancer survivors with the help of Pittsburgh Sleep Quality Inventory (PSQI) total Score; linear mixed effects ANCOVA will assess the variance in mean change when comparing those receiving Partnered YOCAS vs. those on Standard Care and Non-partnered YOCAS respectively. Likewise, PSQI scores will also be"
Are researchers currently recruiting volunteers for this experiment?
"According to information posted on clinicaltrials.gov, this trial is open for enrollment and was first published in December of 2022 with a recent update made at the end of January."
Share this study with friends
Copy Link
Messenger